Rongzi China Releases 2025-2026 Annual Industrial Investment Rankings, Dalton Venture Named "Best Investment Firm in China's Healthcare Sector" | Dalton Honor
On July 30, Rongzi China unveiled its 2025-2026 China Industrial Investment Rankings. Dalton Venture was named **2025-2026 Best Investment Institution in China's Healthcare Sector**, recognized for its professional capabilities across the full investment lifecycle and outstanding performance.
Background
On July 30, Rongzi China unveiled its 2025-2026 China Industrial Investment Rankings. Dalton Venture was named Best Investment Firm in China's Healthcare Sector for 2025-2026, recognized for its end-to-end investment capabilities and strong track record across fundraising, investing, portfolio management, and exits.
Dalton Venture
2025-2026
Best Investment Firm in China's Healthcare Sector
About the Rankings
Rongzi China Research draws on its proprietary database and dedicated research team, conducting surveys, interviews, quantitative analysis, verification, and comprehensive scoring. Investment firms are evaluated through multiple dimensions using a combined quantitative and qualitative methodology, producing one of China's most influential comprehensive rankings in equity and industrial investment. The results were announced at the 2026 China Industrial Investment Summit.
Since its founding, Dalton Venture has been committed to advancing the life sciences and biotechnology industries, with deep, systematic investments across medical devices, innovative technologies, biopharmaceuticals, and bio-manufacturing — delivering strong performance and numerous success stories. As an early-stage investor, we are gratified to see the value of our persistence: several of our earlier bets on breakthrough technologies have now come to fruition, with multiple portfolio companies achieving domestic firsts in scientific and technological innovation.
Going forward, Dalton Venture will continue to deepen its expertise, stay the course, help more outstanding companies achieve transformational growth, and work alongside ecosystem partners to create value for the advancement of medical technology.
ID: daltonventure
Long press to follow
RECOMMENDED READING
Dalton Honors
Dalton Venture Named Among Cailianshe's Top 50 Investment Firms of the Year
Dalton Venture Founding Managing Partner Qi Sun Named to 2025 "Top 30 Angel Investors" List
Dalton Venture Named to Rongzi China's Top 100 VC Firms in China for 2025
Dalton Venture Wins Multiple Honors Including Touzijia's "Top 50 Best Early-Stage Investors of 2025"
Dalton Venture Named to LP Club's "Top 30 Early-Stage Firms Most Followed by LPs" for 2024
Dalton Venture Named Among ChinaVenture's "Top 10 Best Early-Stage Investors in China" for 2023
Qi Sun of Dalton Venture Named Among ChinaVenture's "Best Early-Stage Investors" for 2022-2023
Dalton Venture Named Among CVCRI's "Top 30 Best Healthcare Investors in China" for 2023
Dalton Venture Named Among Touzijia's "Top 60 Best VC Firms" for 2022-2023
Dalton Venture Named Among Yicai's "Top 50 Investment Firms of the Year"
Dalton Venture Named to Rongzi China's "Top 30 Best Healthcare Investors in China" for 2022-2023
Dalton Venture Named Among ChinaVenture's "Top 100 Best VC Firms in China" for 2022
Dalton Venture Named Among ChinaVenture's "Top 20 Best Medical Device Investors" for 2022
Dalton Venture Named Among VBData's "Orange Award: Top 20 Medical Device Investors of the Year"
Dalton Venture Named Among FOFWEEKLY's "Top 20 Healthcare Firms Most Followed by LPs" for 2021
Dalton Venture Makes "Top 100 Best VC Firms in China" for Four Consecutive Years
Dalton Venture Named Among Touzijia's "Top 20 Best Healthcare Investors of 2021"
Dalton Venture Named Among CVCRI's "Top 30 Best Healthcare Investors in China" for 2021
Dalton Venture Named Among "Top 40 Firms Most Favored by LPs" for 2020-2021
Dalton Venture Named "Best Early-Stage Investor in China's Healthcare Industry" for 2020-2021
Dalton Venture Makes "Top 100 Best VC Firms in China" for Three Consecutive Years
Dalton Venture Wins "Top 30 Best Healthcare Investors of 2020" and Other Honors
Dalton Venture Named Among CVCRI's "Top 30 Best Healthcare Investors in China" for 2020